期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Parkinsons Disease LetPub Score 5.2
50 ratings
Rate
Reputation 5.9 Influence 3.8 Speed 9.1 | ||||||||||||||||||||||||
期刊簡稱 | PARKINSONS DIS-US | ||||||||||||||||||||||||
ISSN | 2090-8083 | ||||||||||||||||||||||||
h-index | 37 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.hindawi.com/journals/pd/ | ||||||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | Hindawi Limited | ||||||||||||||||||||||||
主題領域 | CLINICAL NEUROLOGY | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||
每年文章數 | 26每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 100.00% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( USD2000; ) APC waiver:Check Notes Other charges: No Keywords: parkinson's disease Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2090-8083%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 18 Weeks | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Parkinsons Disease] 的評論 | 撰寫評論 |
作者: 桃花子辰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-18 22:58:31 評論於 Just like a crazy person, this publication is the weirdest I've ever seen. After I submitted my article, a stranger emailed me asking for a work email address. I provided one, but the editor never sent anything to that address. Instead, they bombarded my personal email with messages, saying my article title was the same as another article and demanding I change it. They asked me to send the revised title by email, which I found bizarre. At first, I thought it was a scam, but then I realized it wasn't. They kept insisting on changes even though my title was completely different from the other article's. It was like dealing with a crazy person, wasting half a month. I withdrew my submission! I will never submit to that trashy publication under this publishing house again!(0) 讚! | 桃花子辰 |
作者: 桃花子辰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-18 12:27:29 評論於 Psychiatric journal(0) 讚! | 桃花子辰 |
作者: Martin3 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-07-29 10:53:41 評論於 Half a month after submission, it will be reviewed. Two months later, it will be returned for major revisions. In one month, supplementary experiments will be conducted and returned. Minor revisions will be made in half a month, and it will be accepted one week after resubmission.(0) 讚! | Martin3 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:06:45 評論於 Whether the subject matter of the manuscript is suitable for the scope defined by the journal; the readership of the journal; the review and publication timeline of the journal(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:41:21 評論於 Journals in the research field that are recognized for higher acceptance rates or better development of manuscript quality; considerations may include acceptance rates and review speed, among others, if time constraints are a concern(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 16:11:11 評論於 Two journals are equally important, how do you choose which one to submit to?(0) 讚! | 平原文波 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 17:15:47 評論於 Are there any principles for selecting a journal?(0) 讚! | 深渊兴业 |
作者: Nicola Locke 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-15 22:29:47 評論於 This is the first sci, it is a pity that it was accepted in June, and then the IF dropped by 2 points, which is embarrassing(0) 讚! | Nicola Locke |
作者: Derrick Truman 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-06 08:24:16 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: My first Sci paper was accepted, coming back to express my gratitude and hoping to help others. Submitted on 2019-10-20, the status after submission was under review. In early January 2020, major revisions were required with feedback from two reviewers. One recommended rejection and pointed out many issues, while the other suggested minor revisions, mainly focusing on formatting errors and adding a reference. The final decision from the editor was major revisions. It took a whole week to respond to each comment and submit the revised manuscript. By the end of January 2020, the editor requested minor revisions, followed by formatting changes and uploading the revised manuscript. The acceptance notification came by the end of February 2020. The memory is vivid as I received the acceptance during the school closure due to the epidemic, lying in bed. I was thrilled and immediately uploaded the final draft and images. By April 10, it was searchable on PubMed. Overall, based on the journal name alone, it is worth submitting to. I believe this journal has great potential. One flaw may be the repeated requests for emails and publications from participating authors after submission, which can be a bit awkward(0) 讚! | Derrick Truman |
作者: NARY 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-08-31 10:30:01 評論於 The amount of articles accepted in the year is a bit less, in fact not so good.(0) 讚! | NARY |
作者: 碧桃逸致 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-08-31 10:24:47 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: The number of articles accepted annually is a bit low, not as good as it seems(0) 讚! | 碧桃逸致 |
作者: 东慧小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-06-28 11:39:15 評論於 Review Speed: 3.0 | Submission Acceptance Rate: 50.0 Experience Sharing: It is a relatively new journal, so the submission process should be acceptable. The submission process is relatively simple, the review speed is also quite fast, and the acceptance rate listed on the website is 46%(0) 讚! | 东慧小公主 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-06-07 22:45:56 評論於 Review speed: 2.0 | Submission success rate: 75.0 Sharing experience: The specialty journal of PD disease was newly selected for SCI in 2014, showing great potential, and is expected to reach around 3 points in the future(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us